Related Experiment Video
Updated: Jul 28, 2025

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
Transient receptor potential ankyrin 1 (TRPA1) modulators: Recent update and future perspective
Zelin Hu1, Ya Zhang1, Wenhan Yu2
1Department of Pulmonary and Critical Care Medicine, Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China; Precision Medicine Key Laboratory of Sichuan Province & Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China; College of Life Sciences, Sichuan University, Chengdu, 610064, China.
Developing novel TRPA1 modulators is crucial for treating pain, inflammation, and pruritus. This review focuses on structure-activity relationships of recent TRPA1 antagonists and agonists to inspire new drug development.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Transient receptor potential ankyrin 1 (TRPA1) channels detect irritants and are implicated in pain, inflammation, and pruritus.
- TRPA1 antagonists show therapeutic potential but face challenges in clinical efficacy.
- Emerging applications for TRPA1 modulation include cancer, asthma, and Alzheimer's disease.
Purpose of the Study:
- To review recent TRPA1 antagonists and agonists.
- To analyze structure-activity relationships (SARs) and pharmacological profiles.
- To provide insights for developing improved TRPA1-modulating drugs.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of structure-activity relationships (SARs) for TRPA1 modulators.
- Evaluation of pharmacological data for antagonists and agonists.
Main Results:
- Identified key structural features influencing TRPA1 antagonist and agonist activity.
- Highlighted limitations of current TRPA1 antagonists, including selectivity and stability issues.
- Showcased the utility of TRPA1 agonists in understanding activation and screening.
Conclusions:
- Further research is needed to develop TRPA1 antagonists with enhanced selectivity, metabolic stability, and solubility.
- TRPA1 agonists are valuable tools for mechanistic studies and drug discovery.
- This perspective offers inspiration for next-generation TRPA1-targeted therapeutics.
More Related Videos
08:35A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice
Published on: March 17, 2015
08:27Expression and Purification of the Human Lipid-sensitive Cation Channel TRPC3 for Structural Determination by Single-particle Cryo-electron Microscopy
Published on: January 7, 2019
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Mechanically-gated Ion Channels
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Analgesia and Pain Management